Official Publications Cytokinetics, Incorporated

Stocks

Real-time Estimate Cboe BZX Other stock markets 19:03:33 08/06/2026 BST			5-day change	1st Jan Change
68.97 ^USD	-3.51%		-6.39%	+8.55%

06-02	Cytokinetics Insider Sold Shares Worth $1,111,200, According to a Recent SEC Filing	MT
06-01	Cytokinetics announces launch of Myqorzo (aficamten) in Germany for symptomatic obstructive hypertrophic cardiomyopathy	RE

No official publication found